Literature DB >> 10886374

Ste20-like kinase (SLK), a regulatory kinase for polo-like kinase (Plk) during the G2/M transition in somatic cells.

H Ellinger-Ziegelbauer1, H Karasuyama, E Yamada, K Tsujikawa, K Todokoro, E Nishida.   

Abstract

BACKGROUND: Activation of the cyclin-dependent kinase cdc2-cyclin B1 at the G2/M transition of the cell cycle requires dephosphorylation of threonine-14 and tyrosine-15 in cdc2, which in higher eukaryotes is brought about by the Cdc25C phosphatase. In Xenopus, there is evidence that a kinase cascade comprised of xPlkk1 and Plx1, the Xenopus polo-like kinase 1, plays a key role in the activation of Cdc25C during oocyte maturation. In the mammalian somatic cell cycle, a polo-like kinase homologue (Plk1) also functions during mitosis, but a kinase upstream of Plk is still unknown.
RESULTS: We show here that human Ste20-like kinase (SLK), which is a ubiquitously expressed mammalian protein related to xPlkk1, can phosphorylate and activate murine Plk1. During progression through the G2 phase of the mammalian cell cycle, the activity of endogenous SLK is increased. The amount of SLK protein is decreased in quiescent and differentiating cells. Treatment with okadaic acid induces a phosphorylation-dependent enhancement of SLK activity.
CONCLUSIONS: We propose that SLK has a role in the regulation of Plk1 activity in actively dividing cells during the somatic cell cycle. SLK itself is suggested to be regulated by phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886374     DOI: 10.1046/j.1365-2443.2000.00337.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  29 in total

Review 1.  Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Nat Rev Mol Cell Biol       Date:  2013-09       Impact factor: 94.444

2.  Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1.

Authors:  Barbara C M van de Weerdt; Marcel A T M van Vugt; Catherine Lindon; Jos J W Kauw; Marieke J Rozendaal; Rob Klompmaker; Rob M F Wolthuis; René H Medema
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Unique subcellular distribution of phosphorylated Plk1 (Ser137 and Thr210) in mouse oocytes during meiotic division and pPlk1(Ser137) involvement in spindle formation and REC8 cleavage.

Authors:  Juan Du; Yan Cao; Qian Wang; Nana Zhang; Xiaoyu Liu; Dandan Chen; Xiaoyun Liu; Qunyuan Xu; Wei Ma
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Polo-like kinases: structural variations lead to multiple functions.

Authors:  Sihem Zitouni; Catarina Nabais; Swadhin Chandra Jana; Adán Guerrero; Mónica Bettencourt-Dias
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

5.  Ste20-like kinase, SLK, a novel mediator of podocyte integrity.

Authors:  Andrey V Cybulsky; Joan Papillon; Julie Guillemette; Natalya Belkina; Genaro Patino-Lopez; Elena Torban
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

6.  Prostate-derived sterile 20-like kinases (PSKs/TAOKs) are activated in mitosis and contribute to mitotic cell rounding and spindle positioning.

Authors:  Rachael L Wojtala; Ignatius A Tavares; Penny E Morton; Ferran Valderrama; N Shaun B Thomas; Jonathan D H Morris
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

7.  A role for cell polarity proteins in mitotic exit.

Authors:  Thomas Höfken; Elmar Schiebel
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

8.  Polo-like kinase 1 enhances survival and mutagenesis after genotoxic stress in normal cells through cell cycle checkpoint bypass.

Authors:  Gina Chun; Dongsoon Bae; Kristen Nickens; Travis J O'Brien; Steven R Patierno; Susan Ceryak
Journal:  Carcinogenesis       Date:  2010-01-20       Impact factor: 4.944

9.  Ste20-related protein kinase LOSK (SLK) controls microtubule radial array in interphase.

Authors:  Anton V Burakov; Olga N Zhapparova; Olga V Kovalenko; Liudmila A Zinovkina; Ekaterina S Potekhina; Nina A Shanina; Dieter G Weiss; Sergei A Kuznetsov; Elena S Nadezhdina
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

10.  RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.

Authors:  Shilpi Arora; Irma M Gonzales; R Tanner Hagelstrom; Christian Beaudry; Ashish Choudhary; Chao Sima; Raoul Tibes; Spyro Mousses; David O Azorsa
Journal:  Mol Cancer       Date:  2010-08-18       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.